Rowena Sharpe

407 total citations
6 papers, 137 citations indexed

About

Rowena Sharpe is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Rowena Sharpe has authored 6 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Rowena Sharpe's work include Cancer Genomics and Diagnostics (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Rowena Sharpe is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Rowena Sharpe collaborates with scholars based in United Kingdom, Australia and Canada. Rowena Sharpe's co-authors include John Le Quesne, George Santis, Gary Middleton, Crispin T. Hiley, Charles Swanton, David González de Castro, Joshua Savage, Helen Bulbeck, Daniel Slade and Julian Bion and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and BMJ Open.

In The Last Decade

Rowena Sharpe

6 papers receiving 136 citations

Peers

Rowena Sharpe

PRM

CR

MB

ONCOL

PFM

Miguel García-Pardo Canada

Chuangzhou Rao China

Katrin Heider United Kingdom

Fernanda Mosele France

Antoine Vasseur France

Michel Velez United States

Masyar Gardizi Germany

Laia Serrano Spain

Isabel Echavarría Spain

LJ van't Veer United States

Miguel García-Pardo Canada

Rowena Sharpe

86 ×1.1

PRM

83 ×1.2

CR

63 ×1.1

MB

67 ×1.3

ONCOL

15 ×2.1

PFM

Citations per year, relative to Rowena Sharpe Rowena Sharpe (= 1×) peers Miguel García-Pardo

Countries citing papers authored by Rowena Sharpe

Since Specialization

Citations

This map shows the geographic impact of Rowena Sharpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rowena Sharpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rowena Sharpe more than expected).

Fields of papers citing papers by Rowena Sharpe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rowena Sharpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rowena Sharpe. The network helps show where Rowena Sharpe may publish in the future.

Co-authorship network of co-authors of Rowena Sharpe

This figure shows the co-authorship network connecting the top 25 collaborators of Rowena Sharpe. A scholar is included among the top collaborators of Rowena Sharpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rowena Sharpe. Rowena Sharpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Watts, Colin, Joshua Savage, Amit Patel, et al.. (2022). Protocol for the Tessa Jowell BRAIN MATRIX Platform Study. BMJ Open. 12(9). e067123–e067123. 4 indexed citations

2.

Veenith, Tonny, Benjamin A. Fisher, Daniel Slade, et al.. (2021). CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults. BMJ Open. 11(11). e050202–e050202. 3 indexed citations

3.

Middleton, Gary, Sanjay Popat, Yvonne Summers, et al.. (2019). PL02.09 National Lung Matrix Trial (NLMT): First Results from an Umbrella Phase II Trial in Advanced Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 14(10). S7–S7. 1 indexed citations

4.

Hiley, Crispin T., John Le Quesne, George Santis, et al.. (2016). Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease. The Lancet. 388(10048). 1002–1011. 126 indexed citations

5.

Shaw, Emily, Rowena Sharpe, Louise Jones, et al.. (2012). Emerging findings in the Cancer Research UK stratified medicine program.. Journal of Clinical Oncology. 30(15_suppl). TPS10633–TPS10633. 2 indexed citations

6.

Hearn, Julie, et al.. (2011). How Cancer Research UK is adapting to adaptive designs. Trials. 12(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact